同仁堂科技交出的半年报算是差强人意：上半年实现销售收入30.24亿元，同比下滑19.10%；股东应占净利润约2.49亿元，同比下降26.43%——账面数字不算好看，不过也能看出，同仁堂科技正着力重构产品线与品种梯队，在中药零售整体承压的背景下，展现出一定的经营韧性与增长动能。未来纵然不易，但若可在核心产品方面稳住阵脚，从“逆风”到“逆袭”也并非不可能。 产品线重构，“大品种梯队”确立 权威统计...
Source Link同仁堂科技交出的半年报算是差强人意：上半年实现销售收入30.24亿元，同比下滑19.10%；股东应占净利润约2.49亿元，同比下降26.43%——账面数字不算好看，不过也能看出，同仁堂科技正着力重构产品线与品种梯队，在中药零售整体承压的背景下，展现出一定的经营韧性与增长动能。未来纵然不易，但若可在核心产品方面稳住阵脚，从“逆风”到“逆袭”也并非不可能。 产品线重构，“大品种梯队”确立 权威统计...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.